Karen Drexler

Karen is a healthcare industry veteran with a focus on chronic disease management, data analytics, and home and acute user experience-focused machine learning. She has been an active board member for public and private medical device and diagnostics companies for over a decade, and currently sits on the board of ResMed (RSMD:NYSE), Tivic Health and VIDA Diagnostics. Most recently, she was CEO of Sandstone Diagnostics, a life science tools company focused on increased access to high-quality diagnostic testing. Previously, she founded and served as CEO at Amira Medical until its sale to Roche Diabetes Care. Drexler started her career at LifeScan, where she managed a variety of functions and ultimately executed the sale of the company to Johnson & Johnson.